Park Ha Biological Technology is trading at $2.38, down -7.39% on October 8, 2026, with no fresh company-specific catalyst identified. - It fell after closing at $2.57 on October 7; its press-release page lists October 2 as its latest release. - Morning coverage also reported no new company catalyst. Broader markets were softer, but supplied major-index declines were below 0.5%, so the evidence does not establish a market-driven explanation. - The cause of the sharp early decline remains unclear.